Asia Pacific Diabetic Foot Ulcer Treatment Market to Grow at a CAGR of 8.5% to reach US$ 1,723.22 Million from 2021 to 2028

Asia Pacific Diabetic Foot Ulcer Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)

  • Report Code : TIPRE00024703
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 184
Buy Now

Asia Pacific Diabetic Foot Ulcer Treatment Market to Grow at a CAGR of 8.5% to reach US$ 1,723.22 Million from 2021 to 2028

Buy Now

The APAC diabetic foot ulcer treatment market is expected to grow from US$ 976.51 million in 2021 to US$ 1,723.22 million by 2028; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028.

China, India, Japan, South Korea, and Australia are major economies in APAC. Rising research activities to introduce novel wound treatment products is expected to escalate the market growth. Chronic wounds such as diabetic foot ulcers often lead to complications, creating a challenge for surgeons to manage such injuries. With the significant increase in patient pool suffering from chronic wounds, the need for a systematic approach for the treatment has increased, which is encouraging the adoption of evidence-based treatment to make wound care effective. Several research and clinical trials related to chronic wounds management have demonstrated that bioactive wound care products improve the healing of moist wounds more effectively than the traditional wound care products. The active participation of government bodies and research organizations is promoting advancements in the wound care treatments. In December 2018, ConvaTec, a wound care specialist, collaborated with Academic Health Science Networks (AHSN) and the National Health Service (NHS) to improve wound care management. So growing research to introduce treatment will drive the market in coming years.

In case of COVID-19, APAC is highly affected specially India.  People are packing India's public hospitals, as many are unable to afford private ones that generally uphold higher standards of care. The outbreak has severely affected the tourism industry and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission. All these factors will impact the Diabetic Foot Ulcer Treatment market for a short period of time. The focus on the wound care treatments is less as government and population in the region are more focused on the treatment of COVID 19. The dermatology clinics, hospitals, and surgical centers are open for only emergency services. China is specifically facing issues that this epidemic has caused, leading to disruption of the supply chain, projected decreases in revenue and sales within all industries. As the visits to healthcare settings has declined in response to the pandemic to the regions like South Korea and Japan which has negative impact on the wound care industry. In India, shutdown of the entire transportation within the country, and many provinces are establishing border restrictions within the country. This has led to paralyzed supply chains for any industry in India. However, essential medical product supply is not restricted but the production has been affected due to restriction on number of staff working in the companies. As the vaccination progress, the demand for wound care products is expected to increase which will support the diabetic foot ulcer treatment market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC diabetic foot ulcer treatment market. The APAC diabetic foot ulcer treatment market is expected to grow at a good CAGR during the forecast period.  

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

APAC Diabetic Foot Ulcer Treatment Market Segmentation       

APAC Diabetic Foot Ulcer Treatment Market – By Type

  • Advanced Wound Care Dressings
    • Hydrogel Dressings
    • Collagen Dressing
    • Alginate Dressings
    • Foam Dressings
    • Hydrocolloid Dressings
    • Others
  • Biologics
    • Skin Grafts
    • Growth Factors
  • Therapy Device
    • Negative Pressure Wound Therapy
    • Ultrasound Therapy

APAC Diabetic Foot Ulcer Treatment Market – By Ulcer Type

  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuro-ischemic Ulcers

APAC Diabetic Foot Ulcer Treatment Market – By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Home Care

APAC Diabetic Foot Ulcer Treatment Market, by Country

  • China
  • Japan 
  • India
  • South Korea
  • Australia  
  • Rest of APAC

APAC Diabetic Foot Ulcer Treatment Market -Companies Mentioned

  • 3M
  • B. Braun Melsungen AG
  • Cardinal Health Inc
  • Coloplast Group  
  • ConvaTec Group Plc
  • Medline Industries, Inc.
  • MiMedx
  • Mölnlycke Health Care AB.  
  • Organogenesis Inc.
  • Smith & Nephew
  • URGO
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, Ulcer Type, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Australia, China, Japan, South Korea

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Diabetic Foot Ulcer Treatment Market – By Type

1.3.2 APAC Diabetic Foot Ulcer Treatment Market – By Ulcer Type

1.3.3 APAC Diabetic Foot Ulcer Treatment Market – By End User

1.3.4 APAC Diabetic Foot Ulcer Treatment Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Diabetic Foot Ulcer Treatment Market– Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Expert Opinion

5. APAC Diabetic Foot Ulcer Treatment Market – Key Industry Dynamics

5.1 Market Drivers

5.1.1 Escalating Prevalence of Diabetes and Related Chronic Wounds

5.1.2 Surging Geriatric Population

5.2 Key Market Restraints

5.2.1 High Cost of Advanced Wound Care Treatments

5.3 Key Market Opportunities

5.3.1 Rising Research Activities to Introduce Novel Wound Treatment Products

5.4 Future Trends

5.4.1 Burgeoning Use of 3D Printing in Wound Care Management

5.5 Impact Analysis

6. Diabetic Foot Ulcer Treatment Market – APAC Analysis

6.1 APAC Diabetic Foot Ulcer Treatment Marker Revenue Forecast and Analysis

7. APAC Diabetic Foot Ulcer Treatment Market Analysis – By Type

7.1 Overview

7.2 APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by Type (2020 and 2028)

7.3 Advanced Wound Care Dressings

7.3.1 Overview

7.3.2 Advanced Wound Care Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.3.3 Alginate Dressings

7.3.3.1 Overview

7.3.3.2 Alginate Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.3.4 Hydrogel Dressings

7.3.4.1 Overview

7.3.4.2 Hydrogel Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.3.5 Foam Dressings

7.3.5.1 Overview

7.3.5.2 Foam Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.3.6 Collagen Dressing

7.3.6.1 Overview

7.3.6.2 Collagen Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.3.7 Hydrocolloids Dressing

7.3.7.1 Overview

7.3.7.2 Hydrocolloids Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.3.8 Other Dressing

7.3.8.1 Overview

7.3.8.2 Other Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Biologics

7.4.1 Overview

7.4.2 Biologics: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.4.3 Growth Factors

7.4.3.1 Overview

7.4.3.2 Growth Factors: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.4.4 Skin Graft

7.4.4.1 Overview

7.4.4.2 Skin Graft: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.5 Therapy Device

7.5.1 Overview

7.5.2 Therapy Device: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.5.3 Negative Pressure Wound Therapy

7.5.3.1 Overview

7.5.3.2 Negative Pressure Wound Therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

7.5.4 Ultrasound therapy

7.5.4.1 Overview

7.5.4.2 Ultrasound therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

8. APAC Diabetic Foot Ulcer Treatment Market Analysis – By Ulcer Type

8.1 Overview

8.2 APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by Ulcer Type (2020 and 2028)

8.3 Neuropathic Ulcers

8.3.1 Overview

8.3.2 Neuropathic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

8.4 Ischemic Ulcers

8.4.1 Overview

8.4.2 Ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

8.5 Neuro-ischemic Ulcers

8.5.1 Overview

8.5.2 Neuro-ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

9. APAC Diabetic Foot Ulcer Treatment Market– By End User

9.1 Overview

9.2 APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by End User (2020 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

9.4 Ambulatory Surgical Centers

9.4.1 Overview

9.4.2 Ambulatory Surgical Centers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

9.5 Home Care

9.5.1 Overview

9.5.2 Home Care: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

10. APAC Diabetic Foot Ulcer Treatment Market – Country Analysis

10.1 APAC: Diabetic Foot Ulcer Treatment Market Revenue and Forecast to 2028

10.1.1 Overview

10.1.2 APAC: Diabetic Foot Ulcer Treatment Market, by Country, 2020 & 2028 (%)

10.1.2.1 China: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 China: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 China: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)

10.1.2.1.2.1 China: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)

10.1.2.1.2.2 China: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)

10.1.2.1.2.3 China: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)

10.1.2.1.3 China: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)

10.1.2.1.4 China: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Japan: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Japan: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)

10.1.2.2.2.1 Japan: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)

10.1.2.2.2.2 Japan: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)

10.1.2.2.2.3 Japan: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)

10.1.2.2.3 Japan: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)

10.1.2.2.4 Japan: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 India: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 India: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)

10.1.2.3.2.1 India: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)

10.1.2.3.2.2 India: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)

10.1.2.3.2.3 India: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)

10.1.2.3.3 India: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)

10.1.2.3.4 India: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)

10.1.2.4 Australia: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Australia: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Australia: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)

10.1.2.4.2.1 Australia: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)

10.1.2.4.2.2 Australia: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)

10.1.2.4.2.3 Australia: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)

10.1.2.4.3 Australia: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)

10.1.2.4.4 Australia: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)

10.1.2.5 South Korea: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 South Korea: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 South Korea: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)

10.1.2.5.2.1 South Korea: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)

10.1.2.5.2.2 South Korea: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)

10.1.2.5.2.3 South Korea: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)

10.1.2.5.3 South Korea: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)

10.1.2.5.4 South Korea: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of APAC: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Type, 2019–2028 (USD Million)

10.1.2.6.2.1 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings, 2019–2028 (USD Million)

10.1.2.6.2.2 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Biologics, 2019–2028 (USD Million)

10.1.2.6.2.3 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Therapy Device, 2019–2028 (USD Million)

10.1.2.6.3 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Ulcer Type, 2019–2028 (USD Million)

10.1.2.6.4 Rest of APAC: Diabetic Foot Ulcer Treatment Market, by End User, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on APAC Diabetic Foot Ulcer Treatment Market

11.1 APAC: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 ConvaTec Group Plc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 3M

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Coloplast Group

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Smith & Nephew

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 B. Braun Melsungen AG

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Medline Industries, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Cardinal Health Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Organogenesis Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Mölnlycke Health Care AB.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 MiMedx

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 URGO

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Diabetic Foot Ulcer Treatment Market – Revenue, and Forecast to 2028 (US$ Million)

Table 2. China: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3. China: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)

Table 4. China: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)

Table 5. China: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)

Table 6. China: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)

Table 7. China: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8. Japan: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 9. Japan: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)

Table 10. Japan: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)

Table 11. Japan: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)

Table 12. Japan: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)

Table 13. Japan: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14. India: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 15. India: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)

Table 16. India: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)

Table 17. India: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)

Table 18. India: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)

Table 19. India: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 20. Australia: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 21. Australia: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)

Table 22. Australia: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)

Table 23. Australia: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)

Table 24. Australia: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)

Table 25. Australia: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26. South Korea: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 27. South Korea: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)

Table 28. South Korea: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)

Table 29. South Korea: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)

Table 30. South Korea: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)

Table 31. South Korea: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 32. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 33. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)

Table 34. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Biologics– Revenue and Forecast to 2028 (USD Million)

Table 35. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Therapy Device– Revenue and Forecast to 2028 (USD Million)

Table 36. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)

Table 37. Rest of APAC: Diabetic Foot Ulcer Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 38. Organic Developments Done By Companies

Table 39. Inorganic Developments Done By Companies

Table 40. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Diabetic Foot Ulcer Treatment Market Segmentation

Figure 2. APAC Diabetic Foot Ulcer Treatment Market – By Country

Figure 3. APAC Diabetic Foot Ulcer Treatment Market Overview

Figure 4. Advanced Wound Care Dressings Segment Held Largest Share of APAC Diabetic Foot Ulcer Treatment Market by Type

Figure 5. Japan to Show Significant Growth During Forecast Period

Figure 6. APAC: PEST Analysis

Figure 7. Expert Opinion

Figure 8. APAC Diabetic Foot Ulcer Treatment Market Impact Analysis of Driver and Restraints

Figure 9. APAC Diabetic Foot Ulcer Treatment Market – Revenue Forecast and Analysis

Figure 10. APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by Type (2020 and 2028)

Figure 11. APAC Advanced Wound Care Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12. APAC Alginate Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13. APAC Hydrogel Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14. APAC Foam Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15. APAC Collagen Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16. APAC Hydrocolloids Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17. APAC Other Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18. APAC Biologics: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19. APAC Growth Factors: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20. APAC Skin Graft: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21. APAC Therapy Device: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22. APAC Negative Pressure Wound Therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23. APAC Ultrasound therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24. APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by Ulcer Type (2020 and 2028)

Figure 25. APAC Neuropathic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26. APAC Ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27. APAC Neuro-ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 28. APAC Diabetic Foot Ulcer Treatment Market Revenue Share, by End User (2020 and 2028)

Figure 29. APAC Hospitals: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30. APAC Ambulatory Surgical Centers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. APAC Home Care: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32. APAC: Diabetic Foot Ulcer Treatment Market, by Key Country – Revenue (2020) (USD Million)

Figure 33. APAC: Diabetic Foot Ulcer Treatment Market, by Country, 2020 & 2028 (%)

Figure 34. China: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Japan: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. India: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. Australia: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. South Korea: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. Rest of APAC: Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Impact of COVID-19 Pandemic on Diabetic Foot Ulcer Treatment Market in APAC Countries

  1. 3M
  2. B. Braun Melsungen AG
  3. Cardinal Health Inc
  4. Coloplast Group
  5. ConvaTec Group Plc
  6. Medline Industries, Inc.
  7. MiMedx
  8. Mölnlycke Health Care AB.  
  9. Organogenesis Inc.
  10. Smith & Nephew
  11. URGO

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..